Electroencephalography is a widely used method to detect brain and neurological disorders in a person. The most common brain disorders include epilepsy, sleep disorders, and brain tumors. The EEG device involves the usage of electrodes to track electrical signals in the person’s brain, and to check for abnormalities in acquired brain signals. The growing incidences of brain/mental disorders among the population of North America, Europe, and Asia is expected to drive the growth of the global electroencephalograph market in the future.
The global electroencephalograph market holds a major share in the global brain monitoring devices market. The global EEG market is projected to grow at a CAGR of 9.8%, from 2013 to 2018. In terms of geography, the North American and European segments are major contributors to the global market, having accounted for a market share of 52.28% and 25%, respectively. On the basis of application, the main contributing segments of the global EEG market are sleeping disorders and epilepsy, which accounted for a market share of 39.3% and 26.0% in 2013. The sleeping disorders segment is projected to grow at a CAGR of 10.41%, during the given forecast period.
In North America, Europe, and Asia, about one-fifth of the population is said to have been affected by mental/brain disorders. Epilepsy and tumors are highly common among brain disorders in countries, such as the U.S., Germany, and France, whereas sleeping disorders are prominent in the Asian region. Coma & brain death are also highly prevalent in countries, such as India, which is mainly due to the increasing number of severe road accidents. The high incidence of these disorders has significantly increased the demand for brain monitoring devices worldwide. The major companies operating in the global electroencephalograph market include InnerSpace Neuro, Inc. (U.S.), Integra LifeSciences (U.S.), Elekta (Sweden), and Spiegelberg GmbH & Co. KG (Germany) among others.
The global electroencephalograph market report offers in-depth insights on the segmentation of the concerned market. The global EEG market has been classified in terms of application and geography. The major application segments of EEG include brain tumors, sleeping disorders, epilepsy, and coma & brain death among others. On the basis of geography, the global market has been segmented into North America, Europe, Asia, and Rest of the World (RoW). The market report also provides a competitive landscape of key players in this market, along with their market share, financials, and recent developments.
1.1 Analyst Insights
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
2 Executive Summary
3 Market Overview
4 By Applications
4.2 Sleep Disorders
4.3 Coma & Brain Death
4.4 Brain Tumor
5 By Geographies
5.1 North America
5.4 Rest of World
6 By Companies
6.1 Nihon Kohden Corporation
6.2 Natus Medical Inc.
6.3 Grass technologies
6.4 Compumedics Limited
6.5 Cadwell Laboratories, Inc.
6.6 Rimed Ltd
6.8 Compumedics Germany GmbH
6.9 Yokogawa Electric
6.10 Integra LifeSciences Corporation
6.11 Spiegelberg GmbH & Co.
6.12 InnerSpace Neuro, Inc.
6.13 Headsense Medical, Ltd
6.14 Covidien Medical devices
6.15 Nonin Medical Inc.
6.16 CAS Medical Systems, Inc.
6.17 Other Companies
6.18 DePuy Synthes
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
Epilepsy and Sleep Disorders, Coma & Brain Death,
Sleep Disorders and Epilepsy, Coma & Brain Death,
Coma & Brain Death
Coma & Brain Death and Epilepsy, Sleep Disorders,
Brain Tumor and Epilepsy, Sleep Disorders,
North American Electroencephalograph (EEG)
With the increasing incidence of brain disorders in the U.S. and Canada, the demand for EEG and other brain monitoring devices is expected to rise significantly in the coming years. The North American EEG market is anticipated to grow at a CAGR of 9.60%, from 2013 to 2018. The market report provides an overview of the market dynamics, which includes drivers & restraints, opportunities for new entrants, competitive scenario, and market segmentation. The U.S., Canada, and Mexico are countries considered for this extensive market analysis.
European Electroencephalograph (EEG)
The prevalence of mental and neurological disorders, along with increase in healthcare expenditure is expected to drive the growth of the electroencephalograph market in Europe. The European segment is projected to grow at a CAGR of 9.80%, from 2013 to 2018. The market report offers an overview of market segmentation, drivers & inhibitors, and strategic profiling of top players in the market. Germany, France, and the U.K. are countries that have been considered for the extensive market analysis.
Asian Electroencephalograph (EEG)
The rising incidence of brain disorders such as epilepsy or narcolepsy in the highly populated Asian countries, such as India and China is expected to drive the growth of the electroencephalograph market. The Asian market is projected to grow at a CAGR of 10.40%, from 2013 to 2018. The market report presents a detailed analysis of market share, value chain, and market metrics, which includes drivers, restraints, and upcoming opportunities. Deep dive analysis of key market players are also considered in this report.